Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1964 3
1974 2
1975 1
1978 1
1980 5
1982 1
1983 1
1984 8
1985 3
1987 1
1988 1
1989 2
1991 1
1992 1
1993 5
1994 1
1995 5
1996 3
1997 3
1998 3
1999 2
2000 8
2001 12
2002 11
2003 9
2004 8
2005 8
2006 12
2007 13
2008 12
2009 16
2010 33
2011 19
2012 20
2013 17
2014 20
2015 18
2016 19
2017 22
2018 21
2019 21
2020 19
2021 21
2022 21
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
[Classification of cardiomyopathy].
Asakura M, Kitakaze M. Asakura M, et al. Masui. 2014 Jan;63(1):5-15. Masui. 2014. PMID: 24558926 Review. Japanese.
Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial.
Ito S, Takahama H, Asakura M, Abe Y, Ajioka M, Anzai T, Arikawa T, Hayashi T, Higashino Y, Hiramitsu S, Iwahashi N, Izumi C, Kimura K, Kinugawa K, Kioka H, Lim YJ, Matsuoka K, Matsuoka S, Motoki H, Nakamura S, Nakayama T, Nomura A, Sasaoka T, Takiuchi S, Toyoda S, Ueda T, Watanabe T, Yamada A, Yamamoto M, Sozu T, Kitakaze M. Ito S, et al. Among authors: asakura m. Sci Rep. 2023 Aug 2;13(1):12517. doi: 10.1038/s41598-023-39779-y. Sci Rep. 2023. PMID: 37532820 Free PMC article. Clinical Trial.
Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial.
Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y, Mano T, Tsujita K, Igeta M, Okamoto R, Suna S. Ishihara M, et al. Among authors: asakura m. EuroIntervention. 2022 Oct 7;18(8):e647-e655. doi: 10.4244/EIJ-D-22-00269. EuroIntervention. 2022. PMID: 35837711 Free PMC article. Clinical Trial.
Dendritic cell-based cancer immunotherapies.
Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, Shimizu K. Fujii S, et al. Among authors: asakura m. Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):189-98. doi: 10.1007/s00005-009-0025-x. Epub 2009 May 29. Arch Immunol Ther Exp (Warsz). 2009. PMID: 19479202 Free article. Review.
Gelatin Methacryloyl-Riboflavin (GelMA-RF) Hydrogels for Bone Regeneration.
Goto R, Nishida E, Kobayashi S, Aino M, Ohno T, Iwamura Y, Kikuchi T, Hayashi JI, Yamamoto G, Asakura M, Mitani A. Goto R, et al. Among authors: asakura m. Int J Mol Sci. 2021 Feb 6;22(4):1635. doi: 10.3390/ijms22041635. Int J Mol Sci. 2021. PMID: 33561941 Free PMC article.
[Drug-induced heart failure].
Asakura M, Kitakaze M. Asakura M, et al. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:445-9. Nihon Rinsho. 2007. PMID: 18074579 Review. Japanese. No abstract available.
412 results